A New Nanotechnology for Imaging the Juxta-Articular Intraosseous Vasculature-Canal Complex and Related Clinical Pilot Studies
Mengmeng Dou , Jinfeng Yang , Jiaoran Li , Jianmin Li , Zhenzhong Li , Xianhao Shao , Xia Su , Jing Li , Guanghui Wang , Kun Cheng
Orthopaedic Surgery ›› 2025, Vol. 17 ›› Issue (9) : 2744 -2755.
A New Nanotechnology for Imaging the Juxta-Articular Intraosseous Vasculature-Canal Complex and Related Clinical Pilot Studies
Objective: The objective of this study is to achieve distinct visualization of juxta-articular intraosseous microvessels, a novel nanoimaging methodology in which superparamagnetic iron oxide nanoparticles and meglumine diatrizoate (MD) are used cooperatively was implemented.
Methods: A newly created composite of MD and Fe3O4 nanoparticles (MD-Fe3O4 NPs) was prepared as a contrast agent to achieve efficacious imaging of the juxta-articular intraosseous vasculature-canal complex (JIVCC). Scanning electron microscopy (SEM) and energy dispersive spectrum (EDS) were employed to observe the structural characteristics and binding stability of the MD-Fe3O4 NPs. In 20 rabbits that received an injection of MD-Fe3O4 NPs, 1-mm-thick computed tomography (CT) scanning was performed for radiographic assessment. Hematoxylin–eosin- and potassium ferrocyanide-stained sections from 10 sacrificed rabbits were used to observe the histological characteristics of JIVCC with MD-Fe3O4 NPs, and the remaining 10 rabbits were utilized for a systemic safety evaluation. After a healthy volunteer received an MD-Fe3O4 NP injection, we also performed CT scanning and related safety evaluations.
Results: When the MD nanoparticles and amino-Fe3O4 nanoparticles were mixed together, they aggregated into a stable compound structure according to microscopic observations and SEM–EDS verification. In 20 rabbits receiving MD-Fe3O4 injections, 1-mm slice CT imaging demonstrated significantly enhanced visualization of the JIVCCs in magnet-placed knees compared to contralateral limbs (tibial JIVCC: p < 0.001; femoral JIVCC: p < 0.001), confirming MD-Fe3O4 NPs as the efficacious magnetic contrast enhancer. The histological characteristics of MD-Fe3O4 NPs in JIVCC were revealed. The levels of serum iron before and 4 and 72 h after MD-Fe3O4 NP injection were 23.9 ± 2.13 μmol/L, 26.2 ± 2.30 μmol/L, and 24.9 ± 2.33 μmol/L, respectively, indicating that there was no significant difference in safety (p = 0.092). After a volunteer received MD-Fe3O4 NPs via intravenous administration, the JIVCC was clearly visualized, laboratory tests of serum iron levels were normal, and no injection-related complications occurred.
Conclusions: A novel compound nanoparticle, which achieved satisfactory overall outcomes, was implemented as an appropriate alternative for the discernible visualization of juxta-articular intraosseous microvessels. The nanotechnology utilized in this study may augment the clinical imaging methodology for the osseous vascular system.
imaging / intraosseous vasculature / meglumine diatrizoate / nanotechnology / superparamagnetic iron oxide
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
2025 The Author(s). Orthopaedic Surgery published by Tianjin Hospital and John Wiley & Sons Australia, Ltd.
/
| 〈 |
|
〉 |